|
|
Genome analysis reveals interplay between 5′UTR introns and nuclear mRNA export for secretory and mitochondrial genes
|
|
|
|
|
نویسنده
|
cenik c. ,chua h.n. ,zhang h. ,tarnawsky s.p. ,akef a. ,derti a. ,tasan m. ,moore m.j. ,palazzo a.f. ,roth f.p.
|
منبع
|
plos genetics - 2011 - دوره : 7 - شماره : 4
|
چکیده
|
In higher eukaryotes,messenger rnas (mrnas) are exported from the nucleus to the cytoplasm via factors deposited near the 5′ end of the transcript during splicing. the signal sequence coding region (sscr) can support an alternative mrna export (alrex) pathway that does not require splicing. however,most sscr-containing genes also have introns,so the interplay between these export mechanisms remains unclear. here we support a model in which the furthest upstream element in a given transcript,be it an intron or an alrex-promoting sscr,dictates the mrna export pathway used. we also experimentally demonstrate that nuclear-encoded mitochondrial genes can use the alrex pathway. thus,alrex can also be supported by nucleotide signals within mitochondrial-targeting sequence coding regions (mscrs). finally,we identified and experimentally verified novel motifs associated with the alrex pathway that are shared by both sscrs and mscrs. our results show strong correlation between 5′ untranslated region (5′utr) intron presence/absence and sequence features at the beginning of the coding region. they also suggest that genes encoding secretory and mitochondrial proteins share a common regulatory mechanism at the level of mrna export. © 2011 cenik et al.
|
|
|
آدرس
|
department of biological chemistry and molecular pharmacology,harvard medical school,boston,ma, United States, department of biological chemistry and molecular pharmacology,harvard medical school,boston,ma, United States, department of biochemistry,university of toronto,toronto, Canada, department of biochemistry,university of toronto,toronto, Canada, department of biochemistry,university of toronto,toronto, Canada, department of biological chemistry and molecular pharmacology,harvard medical school,boston,ma, United States, department of biological chemistry and molecular pharmacology,harvard medical school,boston,ma, United States, department of biochemistry and molecular pharmacology,howard hughes medical institute,university of massachusetts medical school,worcester,ma, United States, department of biochemistry,university of toronto,toronto, Canada, department of biological chemistry and molecular pharmacology,harvard medical school,boston,ma,united states,center for cancer systems biology,dana-farber cancer institute,boston,ma,united states,donnelly centre for cellular and biomolecular research,university of toronto,toronto,canada,samuel lunenfeld research institute,mt. sinai hospital,toronto, Canada
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|